Contraindicated in:
Use Cautiously in:
CV: chest pain, heart failure.
Derm: alopecia, ERYTHEMA MULTIFORME, ↑ sweating, rash, STEVENS-JOHNSON SYNDROME.
EENT: sinusitis, vision abnormalities.
Endo: hyperthyroidism, hypothyroidism.
GI: abdominal pain, nausea, autoimmune hepatitis, dry mouth, ↑ liver enzymes.
GU: urinary tract infection, polyuria, spontaneous abortion, urinary incontinence.
Hemat: neutropenia, anemia, HEMOLYTIC UREMIC SYNDROME, thrombocytopenia, THROMBOTIC THROMBOCYTOPENIC PURPURA.
Local: injection-site reactions, injection site necrosis.
MS: myalgia, pain, arthralgia, back pain, muscle spasm.
Neuro: depression, dizziness, fatigue, headache, drowsiness, incoordination, rigors, SEIZURES, suicidal ideation.
Resp: upper respiratory tract infection.
Misc: chills, fever, flu-like symptoms, HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS).
Drug-Drug:
Drug-Natural Products:
Avonex
Rebif
Avonex
Rebif
Therapeutic Classification: anti-multiple sclerosis agents, immune modifiers
Pharmacologic Classification: interferons
Absorption: 50% absorbed following subcut administration.
Distribution: Unknown.
Metabolism/Excretion: Unknown.
Half-life: 69 hr (subcut), 10 hr (IM).
NDC Code*